TFA
IDYA icon

Transamerica Financial Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Transamerica Financial Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.76K Hold
101
– – ﹤0.01% 1190
2026
Q1 		$3.37K Buy
101
+40
+66% +$1.34K ﹤0.01% 1113
2025
Q4 		$2.11K Hold
61
– – ﹤0.01% 1121
2025
Q3 		$1.66K Buy
+61
New +$1.48K ﹤0.01% 1076

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Transamerica Financial Advisors's IDYA Position: Q2 2026 in Review

Transamerica Financial Advisors held its IDEAYA Biosciences (IDYA) position steady in Q2 2026 at 101 shares worth $3.76K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Transamerica Financial Advisors first reported a position in IDYA in Q3 2025 and has held it in 4 quarters since. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Transamerica Financial Advisors held 101 shares of IDEAYA Biosciences worth $3.76K as of Q2 2026.
  • Transamerica Financial Advisors left its IDEAYA Biosciences share count unchanged in Q2 2026.
  • IDEAYA Biosciences made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1190 holding.
  • Transamerica Financial Advisors first reported a position in IDEAYA Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.